BIOMAT Database Logo BIOMAT Database Logo

[Results of treatment of newly detected pulmonary tuberculosis with rifampin combined with isoniazid and ethambutol]. 1980

A Szymański, and J Walecki, and E Czaplińska-Jóźwiak, and Z Kuczborska, and A Gaik, and Z Bilczak, and I Swiatnicka, and T Swica, and T Zdawski

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004977 Ethambutol An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863) Dexambutol,EMB-Fatol,EMB-Hefa,Etambutol Llorente,Ethambutol Hydrochloride,Etibi,Miambutol,Myambutol,EMB Fatol,EMB Hefa,Hydrochloride, Ethambutol,Llorente, Etambutol
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

A Szymański, and J Walecki, and E Czaplińska-Jóźwiak, and Z Kuczborska, and A Gaik, and Z Bilczak, and I Swiatnicka, and T Swica, and T Zdawski
[Results of 6-month and 9-month treatments with rifampin, isoniazid and ethambutol in cases of newly detected tuberculosis].
January 1981, Revista de igiena, bacteriologie, virusologie, parazitologie, epidemiologie, pneumoftiziologie. Pneumoftiziologia,
A Szymański, and J Walecki, and E Czaplińska-Jóźwiak, and Z Kuczborska, and A Gaik, and Z Bilczak, and I Swiatnicka, and T Swica, and T Zdawski
[Remote results of short-term treatment of pulmonary tuberculosis with a combination of isoniazid, rifampin and ethambutol].
November 1980, Pneumonologia polska,
A Szymański, and J Walecki, and E Czaplińska-Jóźwiak, and Z Kuczborska, and A Gaik, and Z Bilczak, and I Swiatnicka, and T Swica, and T Zdawski
Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
November 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
A Szymański, and J Walecki, and E Czaplińska-Jóźwiak, and Z Kuczborska, and A Gaik, and Z Bilczak, and I Swiatnicka, and T Swica, and T Zdawski
[Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
July 1980, Pneumonologia polska,
A Szymański, and J Walecki, and E Czaplińska-Jóźwiak, and Z Kuczborska, and A Gaik, and Z Bilczak, and I Swiatnicka, and T Swica, and T Zdawski
Re-treatment of pulmonary tuberculosis with rifampin and ethambutol.
January 1972, The American review of respiratory disease,
A Szymański, and J Walecki, and E Czaplińska-Jóźwiak, and Z Kuczborska, and A Gaik, and Z Bilczak, and I Swiatnicka, and T Swica, and T Zdawski
Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
March 1971, The American review of respiratory disease,
A Szymański, and J Walecki, and E Czaplińska-Jóźwiak, and Z Kuczborska, and A Gaik, and Z Bilczak, and I Swiatnicka, and T Swica, and T Zdawski
Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases.
June 1972, Chest,
A Szymański, and J Walecki, and E Czaplińska-Jóźwiak, and Z Kuczborska, and A Gaik, and Z Bilczak, and I Swiatnicka, and T Swica, and T Zdawski
[Ethambutol combined with streptomycin and isoniazid for the original treatment cases of pulmonary tuberculosis].
February 1970, Kekkaku : [Tuberculosis],
A Szymański, and J Walecki, and E Czaplińska-Jóźwiak, and Z Kuczborska, and A Gaik, and Z Bilczak, and I Swiatnicka, and T Swica, and T Zdawski
Therapeutic efficacy of rifampin in newly detected pulmonary tuberculosis.
May 1974, Canadian Medical Association journal,
A Szymański, and J Walecki, and E Czaplińska-Jóźwiak, and Z Kuczborska, and A Gaik, and Z Bilczak, and I Swiatnicka, and T Swica, and T Zdawski
Treatment of chronic drug-resistant pulmonary tuberculosis with rifampin and ethambutol.
April 1972, Canadian Medical Association journal,
Copied contents to your clipboard!